As hypothesized, SLIT2 silencing in APL cell lines and primary APL cells led to increased cell proliferation, cell cycle progression, and resistance to ATO/ATRA drug induced apoptosis. This evidence concerns the gene SLIT2 and acute promyelocytic leukemia.